XBiotech names director
Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
XBiotech Inc. elected Donald MacAdam as a board member.
MacAdam is currently a director of Hammond Power Solutions Inc. and has previously served as CEO of MBVax Bioscience Inc.
Austin, Texas-based XBiotech develops antibodies for treating diseases such as cancer, inflammatory conditions and vascular diseases.